DatasetName,NUP205_S(1016) NUP205_S(1153) NUP205_S(1164) NUP205_S(1165) NUP205_S(1167) NUP205_S(1939) NUP205_S(1942) NUP205_S(71) NUP205_S(942) NUP205_T(1225) NUP205_T(1944) NUP205_T(3) NUP205_Y(581),NUP205_S(219)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.47502331559624317,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.4764009982026804,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.48431775710637776,
RKK2015_TNF-α/basal,0.4958118046897391,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.48366599276592126,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.4760844163505987,
JW2015_Intensity pre1,0.4953860080250089,
IMM2018_normalised rep. int. Empty-3,0.4907874639398258,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.4909577845114144,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.48782650330388105,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.4990494270962775,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,0.5167306705081212,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,0.4820817479819765,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.513346720220295,
WZ2023_Pu_010_30min,0.48054048672874256,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.47817089086549774,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.451647958008777,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.503626820302975,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),0.4781668869604294,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,0.4901580178273172,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.482777151998563,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.4678791390125612,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.515269783310944,
RM2024_Intensity D4-3___3,0.4706735261383775,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.49189743667347136,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,0.4710923196810472,
WZ2023_Pe_025_10min,0.4675376013125368,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.4819834425640852,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.4877713491879779,
AH2018_SILAC_MR_2_X,0.49540791916616544,
HS2024_4_PD_T2,0.48828816758677324,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,0.4822764500493039,
CR2017_Ratio Replicate 1.4,0.4891049285178519,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.48176609593937847,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.48806418894739473,
HS2024_7_PD_T2,0.47884567201439887,
FSO2013_Ratio H/L normalized Rep1___1,0.4916041604388982,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4790659311460332,
HS2024_3_B_N1,0.5114477322040165,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4674440423630205,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.48774255828107815,
MV2014_Ratio H/M normalized A2___2 (2 min),0.5043170804206565,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5011457288831905,
FSO2013_Ratio H/L normalized Rep2,0.5010978309648433,
WZ2023_Pu_005_20min,0.48477491906766673,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4959740838039188,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.49797199449632856,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.4648945872919352,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.4787854639204979,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5282078707137532,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.48425783268194034,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.47457158100435903,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.4816072236932557,
PG2020_Intensity Mock_10h_D,0.4798875267961184,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5206351144870578,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.46562044741691905,
RCJD2014_5min_1,0.49642299325126316,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.485470199174589,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.4915925967457709,
CR2017_Ratio Replicate 3.3,0.4992661229090997,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5162723261667526,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.49028039928119027,
HS2024_5_PD_T1,0.5091142927294752,
AH2018_LFQ_M_2_C,0.4706155338352349,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.4946195970683469,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.4850991752947852,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.48208155790303225,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4851709734143638,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.4814810906169311,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5292019971440348,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,0.487040980414678,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.4963309452249393,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.4969591800851552,
HS2024_8_I_T3,0.5075939262850433,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5220460119453442,
DL2023_12h-2,0.4866792633301771,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4873018135390437,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.48559733375096287,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.48537578712460605,
FSO2013_Ratio H/M normalized Rep2,0.4941382809201382,
RAM2015_Log2 A,,
HS2024_8_PD_T1,0.5038152804305519,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.4941703525295132,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.4894389715620254,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.46798427834630285,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.4947608356654473,
AH2018_SILAC_M_3_X,0.48215942654809163,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.47856072231416324,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.4914109564020462,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5136216903137665,
HS2024_6_B_N1,0.48136604564604835,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.49009374024549596,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.47377369995788077,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.48923665597782756,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.486911432477869,
DL2023_control-1,0.4848450621918193,
AR2021_ALG 10 μM,0.4877316280381833,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.48660335910810054,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.487616932339513,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.4923059791726313,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.4854397858398232,
JW2021_After_3,0.5023325709399198,
GF2025_P8_Sph,0.4941320945265708,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.4877206262286604,
CK2022_11 200-1,0.48101750120621783,
CK2022_12 200-1,0.48071475664492136,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.48074522555322824,
WZ2023_Su_010_20min,0.484577629356295,
AH2018_TMTMS2_2_N,0.45787536321412337,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.4826962717610208,
KS2014_Intensity N4,0.4823535219241437,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,0.4901704032168351,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.4816346143158891,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4874473559595404,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,0.5022195869812184,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.4931545753298133,
GF2025_P1_Sph,0.49983146376587295,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.48202030782447014,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.48866424256775554,
CF2017_EOC 1,,
CK2022_3 200-1,0.4816222435452459,
AH2018_LFQ_IT_3_C,0.48714277789718846,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.47723888002162257,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.49017850173892524,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5163914640434512,
HS2024_5_B_T1,0.49044651082463225,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.48676588106318797,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5075460452621133,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4815200021803066,
JW2021_Before_2,0.4865446397832955,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.47403487556177026,
HS2024_4_B_T1,0.4992364923546091,
MV2014_Ratio M/H normalized A3___1 (10 min),0.4815685575484002,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.4804449682185289,
CR2017_Ratio Replicate 3.2,0.49743443729181813,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.48445631693106034,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,0.49178470713207745,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.4810220019173428,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4848393370716314,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.4796798354811544,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.4876881378057894,
HS2024_5_PD_T3,0.4778842429566438,
AH2018_TMTMS3_3_X,0.48215202746840574,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.4683031529313441,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.48326155317517805,
AH2018_SILAC_M_1_N,0.48046602465380744,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.4777166034268533,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,0.4906778963715132,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5328442125422252,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.49561047311917333,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,0.4877863196996887,
LY2019_P3+,0.48065538713862216,
HH2022_Reporter intensity 6,0.4831183318208628,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.48762214311288987,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.45697669159789744,
GF2025_P3_Adh,0.4956743832187514,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.4559185510025886,
RM2024_Intensity D0-1___2,0.49124194697726264,
LY2019_P4+,0.48875120414547124,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.4724138059223875,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5106484868949097,
AH2018_LFQ_1_X,0.4626431401034618,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.48697154839796875,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.4886048875612966,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,0.49290462882592573,
RM2024_Intensity D6-2___2,0.4875666528209851,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,0.49090006411939424,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5292833165626666,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.4497734705540356,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4953469557473205,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4884636330964367,
AR2021_KD 72h,0.4798840345343586,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4825137520766339,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.48187787440835284,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,0.48957642738752605,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.47974002931324244,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.48448278300555975,
HS2024_7_B_N2,0.4954989709956191,
PG2020_Intensity 10h_A,0.46656952625384174,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.4812780060114201,
SAS2015_PLX/AZD_Exp1,0.5581352241060192,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,0.4943300330151368,
BS2014_Log2(Ratio H/L normalized Rep_2),0.47712099157460375,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,0.485984661158966,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,0.4961573161348062,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5076313687189852,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5297987822396383,
CK2022_7 200-1,0.4860668880715994,
CK2022_5 200-1,0.4861130245197972,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5012887568830432,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.45735381356376714,
AH2018_SILAC_MR_1_X,0.4785455656168711,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.490450620816272,
RM2024_Intensity D4-1,0.48853394724925214,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.48128536995007143,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.49333707428344264,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.45847572358426397,
SAS2015_PLX/DMSO_Exp1,0.5310700561555783,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.49981666007092956,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.49813284057200824,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.48243655377775724,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5162691705054776,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.4866771046713791,
AH2018_SILAC_IT_1_X,0.4895911576210267,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.48361856290956773,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.49193487688283055,
WZ2023_Pe_025_20min,0.4819312614320554,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.4775094445632874,
HS2024_4_I_N2,0.4918489601193531,
AH2018_TMTMS2_3_N,0.45503521447714956,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4807412942867864,
WZ2023_Su_005_30min,0.479750780721367,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5324456075326912,
WZ2023_Su_025_10min,0.48428925290686564,
AH2018_LFQ_IT_4_X,0.48173362090020294,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,0.48120719287015834,
WZ2023_Su_005_20min,0.4806164139942709,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.47357223422769723,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5287601922420533,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.48076867618375674,
MV2014_Ratio H/M normalized A2___1 (2 min),0.4874128063793858,
PG2020_Intensity 8h_D,0.4647227208090684,
LY2019_P7+,0.4918608587210256,
EP2017_Untreated R#1 normalized log2 ratio,0.49910493664229494,
RN2012_L10,,
PG2020_Intensity 4h_C,0.4738959345856238,
EP2017_Mitotic R#3 normalized log2 ratio,0.47082654979571825,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.4900520482134608,
HS2024_4_B_T3,0.4839191491564154,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.46623085512486906,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.4780893011323687,
KBE2022_Log2_Ex_6_U,0.4766664704389235,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.4899190012034647,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.48125284857274414,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.45988222098356873,
GF2025_P9_Sph,0.4904289073822427,
CK2022_6 200-1,0.48578858144040754,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.48116914384154386,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,0.4862298732995801,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.4721398709250563,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.4836285558037478,
SAS2015_AZD/DMSO_Exp1,0.4943474213107964,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.4898023267454532,
HS2024_3_B_T3,0.49119627258878096,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.495003977685386,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.485387734583416,
KS2014_Intensity pY_C4,0.4661313929309744,
CR2017_Ratio Replicate 3.5,0.49388358492304757,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5209305301340746,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,0.4891286952430232,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.4871749352510382,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.49521740404198006,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.4823549911635411,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.4728657629696868,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.49928754041057055,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.45518844986005713,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,0.48924436151987216,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,0.4889866863838895,
KBE2022_Log2_Ex_39_U,0.480436285802315,
EP2017_Untreated R#3 log2 ratio,0.49527392003255855,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5000333388576865,
HS2024_8_PD_T2,0.5199479912905748,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,0.4878220318598882,
HS2024_8_B_N1,0.46677917475214775,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.4779301205945268,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5196740162729483,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4927828964992308,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4827080832298446,
HS2024_3_PD_T3,0.5032724150433526,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.4863716784199881,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.4759241041265107,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,0.48836418023684397,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.4850262564024144,
HS2024_7_PD_T3,0.4982170792229474,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.4739691321173598,
AH2018_LFQ_4_N,0.46006062640698225,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.48680982284449836,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.4884239308527609,
AH2018_SILAC_M_1_X,0.48605256477167763,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.48463880646455515,
LY2019_P6+,0.49200910383993085,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.48425738586434564,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5156378478698685,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.48392643920048556,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.513414417245502,
RM2024_Intensity D0-1,0.47699777572132207,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.48765232886279375,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.49373491493626026,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.47234325898431345,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.47513243646769765,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4948180022439054,
GF2025_P3_Sph,0.4964043281828362,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),0.4684023457651454,
AH2018_SILAC_1_C,0.4843481310601241,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.48627698618627896,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5131711741524672,
ZQ2022_N1,,
LY2019_P6-,0.49639347057232724,
RM2024_Intensity D2-3,0.47757937242580145,
UK2020_HCM_1,,
JW2015_Intensity pre2,0.49472624200749604,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,0.4899918276559812,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.47241171045883196,
RKK2015_TNF-α/IKKb,0.48174388916425254,
SFR2015_HL_log2_ratio_std_b,0.4825888629999916,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,0.4890170101563113,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.4779994870914485,
WZ2023_Su_025_20min,0.4559941402669813,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.4905132648531628,
LY2019_P8-,0.4960709175555275,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.49070928967937844,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.48338028495141033,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5043503311507183,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5170603389291999,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.4937673565989619,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.45272036217399325,
AH2018_LFQ_M_4_C,0.4890741770549246,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.4773224541482801,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4784501020521226,
LY2019_P3-,0.4909650253563646,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),0.4851024271434887,
WZ2023_Pe_005_30min,0.49351207299470645,
HS2024_8_PD_T3,0.5025563746597523,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,0.4947906639031382,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.49189827346747933,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.49137422683339727,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.4515216277654368,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.4553826196726921,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.4807666580084028,
HS2024_8_I_N2,0.4754626042885727,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.4959232775936479,
LY2019_P8+,0.4816600158097083,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.48347321375921337,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.4932635184013969,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.48063664331209366,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.4954728774380327,
AH2018_LFQ_IT_1_X,0.4867664812445837,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4869671535725064,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5087142663284427,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5146718343601666,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.4971083294289549,
HS2024_6_I_T1,0.48786187712848633,
HS2024_5_B_T3,0.5015803495252107,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.4807127482149437,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.4684325696285875,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4745384576791356,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.486123025113929,
KS2014_Intensity C2,0.5181473503494255,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,0.477422304342039,
KBE2022_Log2_Ex_42_T,0.4782564040576698,
CK2022_9 200-1,0.4809163773529441,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.48106298138116554,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5056863684381061,
RBK2021_1332T Late,,
LY2019_P1-,0.4770261248188007,
RKK2015_TNF-α/basal.1,0.4773380598911988,
RKK2015_TNF-α/TNF-α+SC-514,0.5028449415217188,
CR2017_Ratio Replicate 2.5,0.5040222531360198,
HS2024_3_I_T3,0.5281250474650135,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.4879845244953555,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.48113271453270706,
FSO2013_Ratio H/M normalized Rep3___2,0.4853147419578553,
RM2024_Intensity D6-2,0.487754267775683,
EP2017_Untreated R#1 log2 ratio,0.49933763051554286,
RKK2015_SC-514/basal,0.4733118298520643,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4769898521814956,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5158124944223161,
KS2014_Intensity N1,0.485601667095385,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4994491020963657,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.4565820710891288,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.46784804523882734,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.4883894300639667,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.477274768096409,
HS2024_5_I_N1,0.4709442147806783,
HS2024_6_I_N1,0.5072108404569176,
AR2021_KD 48h,0.4986564130382102,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5004760095511109,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4866573345090935,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5052287255682266,
AH2018_LFQ_M_2_X,0.4706831110706187,
AH2018_LFQ_IT_4_N,0.481476397542427,
CK2022_15 200-1,0.48209431849519874,
RM2024_Intensity D4-1___2,0.49170451065956056,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.49341747490521126,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4811014401734245,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.49066254152365024,
WZ2023_Su_010_30min,0.47807039287227965,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5275285383116948,
HS2024_8_B_T3,0.5035711040523764,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.48865423029836735,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5029035698267557,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.48383714476080986,
KS2014_Intensity C1,0.5051033340845321,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.4817733718317111,
RKK2015_TNF-α+IKKb/TNF-α,0.4762420209991995,
RM2024_Intensity D0-3___2,0.49217518202445104,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.48747611435674565,
AH2018_SILAC_M_2_X,0.4873431316273655,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.47892569892675113,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4873560437971754,
PG2020_Intensity 6h_C,0.47849572277447294,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.48106944175928223,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.4586060834365969,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.4917555087176503,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,0.4825931390914176,
HS2024_3_I_N2,0.5065251301605861,
GF2025_P8_Adh,0.48809727221288995,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.49860213388642516,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.4902030383568732,
IMM2018_normalised rep. int. CDK5L-1,0.48995318666883086,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.46274229360246755,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.48950525776628784,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.48536842008375736,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5064273926834215,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.479864455527081,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4914639718437759,
RM2024_Intensity D2-2___2,0.4916844397231997,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.45724581357542593,
AR2021_L41 1 μM,0.49114682715462643,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.45641923118863015,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5089854197676691,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.4987160134991386,
MV2014_Ratio H/M normalized B2___1 (5 min),0.4801540277785273,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.48820416678665424,
SAS2015_PLX/DMSO_Exp3,0.5283891731531414,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.4890944460747301,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.4848446154896138,
WZ2023_Pu_025_10min,0.48904365707736097,
RM2024_Intensity D2-2___3,0.4701130049509645,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.477123055329482,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4876086852618246,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.48766696332979376,
KS2014_Intensity C6,0.5058149220719865,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.4864328217951491,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.49892148443216944,
GF2025_P5_Adh,0.4864266756801689,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5001209967778585,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),0.48626745204856275,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.48760664624562094,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.4934306558008223,
KS2014_Intensity pY_E5_1,0.47277882758499307,
JW2021_Before_3,0.4844900640835814,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.4775511661543436,
AH2018_LFQ_3_C,0.49429727828573355,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.4730185852054095,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.49251286882133716,
RB2022_2_PreEndurance,,
JW2021_Before_1,0.48335869653782965,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),0.49515091635186764,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),0.48660079656649646,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.4944079633942397,
HS2024_8_I_T1,0.5128593714877663,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.46806304010284067,
AH2018_TMTMS2_1_X,0.45912517618970994,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5092575990142835,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.4866593104890319,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.4964965722628843,
AH2018_SILAC_1_X,0.486760910107729,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.48716307428833405,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.4737682160789356,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.4496437168516589,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.48095148433904505,
HS2024_5_I_N2,0.47009951578048936,
SAS2015_PLX/AZD_Exp3,0.5209844259497669,
EP2017_Pervanadate R#2 log2 ratio,0.5227308936669203,
AS2011_Ratio H/L Normalized RNAi_2_1,,
